The probe is directed at all CAR-Ts currently ... positive lymphoma – in patients who had received both types of CAR-T therapy. The regulator highlighted the products by name, including Bristol- ...
The findings could lead to more precise engineering of CAR-T cells, allowing them to attack cancer more effectively while potentially alleviating some of the side-effects of the therapy ...
CAR T cell therapy has revolutionized cancer care, providing a powerful option for some blood cancers. No treatment is perfect, however, and some patients develop resistance to CAR T cell therapies.
CAR T-cell therapy modifies T cells to target cancer, showing promise in multiple myeloma treatment High costs and limited access make advanced cancer therapies unaffordable for many in India ...
From the heart of the English commuter town, UK biotech Autolus will process, manufacture and ship to the US a new Car-T cell therapy to treat the blood cancer acute lymphoblastic leukaemia (ALL ...
CAR T cell therapy has revolutionized cancer care, providing a powerful option for some blood cancers. No treatment is perfect, however, and some patients develop resistance to CAR T cell therapies.
In 2018, England was the first country in Europe to provide access to a CAR-T cell therapy to treat these blood cancers, enabled via the Cancer Drugs Fund (CDF). Since then, over 500 patients in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results